Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated just now
Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer

1012 Rational design of selective IL-2-based activators for CAR T cells Using AlphaFold3 and physics-informed machine learning

  • Zakaria L Dahmani1
  1. 1University of Pittsburgh, Pittsburgh, PA, USA
Open at sourcePDFDOICite

Related

  1. Toward selective amyloid clearance through rational nanomedicine design
    Tianyi Qi, Jie Zhuang, Yuejuan Cao +1
    Clinical and Translational MedicinePeer-reviewedCC BYFull textPhysiologyDOAJ
  2. Affinity maturation of a single-domain antibody via rational mutagenesis informed by artificial intelligence
    S. L. Tetteroo, C. Tawiah, G. Dekkers +1
    bioRxivPreprintCC BY-NDFull textMedical imaging & radiologybioRxiv
  3. Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer
    Ida Aronchik, Sumit Kar, Yongxian Zhuang +43
    Nature MedicinePeer-reviewedCC BYFull text20 citedOncologyOpenAlex
  4. Thromboelastographic Assessment of the Differential Sensitivity of Three Contact Activators to Coagulation Factor Deficiencies in Hemocell Environments
    Weiguo Liang, Mao Xia, Junpo Li +3
    Diagnostics (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. A phytocannabinoid-sensitive phosphorylation switch converts endocannabinoids into alternative lipid GPCR activators
    A. C. Love, Y. Kihara, H. Mizuno +6
    bioRxivPreprintAll rights reservedFull textPharmacology & toxicologybioRxiv

Cite

BibTeXRIS
BibTeX
@article{dahmani20261012,
  title = {{1012 Rational design of selective IL-2-based activators for CAR T cells Using AlphaFold3 and physics-informed machine learning}},
  author = {Zakaria L Dahmani},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  month = nov,
  doi = {10.1136/jitc-2026-sitc2026.1012},
  url = {https://doi.org/10.1136/jitc-2026-sitc2026.1012},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - 1012 Rational design of selective IL-2-based activators for CAR T cells Using AlphaFold3 and physics-informed machine learning
AU  - Zakaria L Dahmani
PY  - 2026
DA  - 2026/11/07
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-sitc2026.1012
UR  - https://doi.org/10.1136/jitc-2026-sitc2026.1012
SN  - 2051-1426
ER  -